A study has analyzed, for the first time, the mechanisms underlying the use of focused ultrasound to improve the delivery of anti-cancer drugs across the blood brain barrier into brain tumors.
Researchers reveal techniques — inspired by the study of information theory — to track how changes in precipitation alter interactions between the atmosphere, vegetation and soil at two National Science Foundation Critical Zone Observatory sites in the western United States.
The insights could open the door to a more effective treatment approach for patients with rare disorder.
Scientists have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide.
Drugs currently undergoing development to treat anaemia could be repurposed to help prevent people with Type 2 diabetes from developing heart failure, according to new research.
Decades after scientists discovered hundreds of different fatty acids in vegetable oils, two that had managed to elude detection have finally revealed themselves. The discovery may be the first of its kind since the 1960s and 1970s, the researchers said, when biochemists identified troves of new fatty acids in various vegetable oils.
The upcoming version of Windows 10, which industry watchers expect will arrive in September, has many monikers. Its version number is 1809, and its code name is Redstone 5. Microsoft has not yet annou..
In 2013, researchers found an association between genetic variants in FKBP5 and posttraumatic chronic pain. Now a new study by the same research group has confirmed this association in a cohort of more than 1,500 people of both European-American and African-American descent who experienced motor vehicle collision trauma.
A new study establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information. By designing an algorithm and developing it to analyse CT scan images, medical researchers specializing in artificial intelligence in oncology-radiotherapy and precision medicine) have created a so-called radiomic signature.
Sucralose, a widely used artificial sweetener sold under the trade name Splenda®, is metabolized in the gut, producing at least two fat-soluble compounds, according to a recent study using rats. The finding differs from the studies used to garner regulatory approval for sucralose, which reported that the substance was not broken down in the body.